Detalles de la búsqueda
1.
Variant allele frequency in baseline circulating tumour DNA to measure tumour burden and to stratify outcomes in patients with RAS wild-type metastatic colorectal cancer: a translational objective of the Valentino study.
Br J Cancer
; 126(3): 449-455, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34811502
2.
Reinduction of an Anti-EGFR-based First-line Regimen in Patients with RAS Wild-type Metastatic Colorectal Cancer Enrolled in the Valentino Study.
Oncologist
; 27(1): e29-e36, 2022 02 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35305093
3.
Multi-institutional analysis of outcomes for thermosphere microwave ablation treatment of colorectal liver metastases: the SMAC study.
Eur Radiol
; 32(6): 4147-4159, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35092474
4.
Response shift in health-related quality of life measures in the presence of formative indicators.
Health Qual Life Outcomes
; 19(1): 9, 2021 Jan 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33407569
5.
Italian results of the PRECONNECT study: safety and efficacy of trifluridine/tipiracil in metastatic colorectal cancer.
Future Oncol
; 17(18): 2315-2324, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33663264
6.
Systemic doxycycline for pre-emptive treatment of anti-EGFR-related skin toxicity in patients with metastatic colorectal cancer receiving first-line panitumumab-based therapy: a post hoc analysis of the Valentino study.
Support Care Cancer
; 29(7): 3971-3980, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33392769
7.
AtezoTRIBE: a randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorectal cancer.
BMC Cancer
; 20(1): 683, 2020 Jul 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-32698790
8.
Metastatic colorectal cancer prior to expanded RAS assessment: evidence from long-term outcome analysis of a real-life cohort within a dedicated colorectal cancer unit.
World J Surg Oncol
; 18(1): 65, 2020 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32241284
9.
HER2 Positivity Predicts Unresponsiveness to EGFR-Targeted Treatment in Metastatic Colorectal Cancer.
Oncologist
; 24(10): 1395-1402, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30952821
10.
Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer.
Gut
; 67(11): 1995-2005, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28982739
11.
Dose to Pelvic Bone Marrow Defined with FDG-PET Predicts for Hematologic Nadirs in Anal Cancer Patients Treated with Concurrent Chemo-radiation.
Cancer Invest
; 36(5): 279-288, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29953269
12.
Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial.
Lancet Oncol
; 17(6): 738-746, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27108243
13.
Recommendations for the Prophylactic Management of Skin Reactions Induced by Epidermal Growth Factor Receptor Inhibitors in Patients With Solid Tumors.
Oncologist
; 21(12): 1483-1491, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27449521
14.
Assessment of a HER2 scoring system for colorectal cancer: results from a validation study.
Mod Pathol
; 28(11): 1481-91, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26449765
15.
Intensity-modulated radiation therapy with simultaneous integrated boost combined with concurrent chemotherapy for the treatment of anal cancer patients: 4-year results of a consecutive case series.
Cancer Invest
; 33(6): 259-66, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25950188
16.
Circulating immunosuppressive cells of prostate cancer patients before and after radical prostatectomy: profile comparison.
Int J Urol
; 20(10): 971-8, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23421558
17.
Temozolomide Followed by Combination With Low-Dose Ipilimumab and Nivolumab in Patients With Microsatellite-Stable, O6-Methylguanine-DNA Methyltransferase-Silenced Metastatic Colorectal Cancer: The MAYA Trial.
J Clin Oncol
; 40(14): 1562-1573, 2022 05 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35258987
18.
Impact of early tumor shrinkage and depth of response on the outcomes of panitumumab-based maintenance in patients with RAS wild-type metastatic colorectal cancer.
Eur J Cancer
; 144: 31-40, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33321462
19.
The Added Value of Baseline Circulating Tumor DNA Profiling in Patients with Molecularly Hyperselected, Left-sided Metastatic Colorectal Cancer.
Clin Cancer Res
; 27(9): 2505-2514, 2021 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33547199
20.
Prospective, randomised, multicentre, open-label trial, designed to evaluate the best timing of closure of the temporary ileostomy (early versus late) in patients who underwent rectal cancer resection and with indication for adjuvant chemotherapy: the STOMAD (STOMa closure before or after ADjuvant therapy) randomised controlled trial.
BMJ Open
; 11(2): e044692, 2021 02 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-33608405